Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke

Katherine Harrison, Ashley Petersen, Nicole Tosun, Katherine Crist, Alicia M. Allen, Sharon Allene

Research output: Contribution to journalArticle

Abstract

Cigarette smoking-related symptomatology (e.g., craving; SRS) is linked to relapse after a quit attempt. SRS varies by menstrual phase, possibly due to variations in sex hormones (e.g., progesterone), though much of the research to-date has relied on observations from the menstrual cycle acting as a proxy for hormone levels. The goal of this study was to examine the effect of exogenous progesterone on SRS during ad libitum smoking and following overnight abstinence. Oral contraceptive users who smoked completed two 9-day crossover testing periods (7 days of ad libitum smoking and 2 days following overnight abstinence) while taking double-blind active/placebo exogenous progesterone. Participants completed questionnaires to measure SRS. The effect of exogenous progesterone and endogenous hormones (progesterone, estradiol, and progesterone-to-estradiol [P/E2] ratio) on SRS was assessed with paired t-tests and linear mixed effect models. Participants (n = 53) were, on average, 24 years old and smoked 11 cigarettes per day. During ad libitum smoking, a doubling of the P/E2 ratio was associated with 0.09 points lower anticipated relief from negative affect (95% confidence interval [CI]: 0.03–0.15 points lower; p = 0.008) and 0.11 points lower psychological reward (95% CI: 0.03–0.18 points lower; p = 0.006). After correction for multiple testing, these associations were not statistically significant: anticipated relief from negative effect (p = 0.10) and psychological reward (p = 0.09). No other significant associations were observed. Although substantial previous literature indicates that progesterone influences SRS, exogenous progesterone administration did not alter SRS here. Additional research is needed to elucidate alternative mechanisms involved in menstrual phase effects on SRS.

Original languageEnglish (US)
Article number106148
JournalAddictive Behaviors
Volume102
DOIs
StatePublished - Mar 2020

Fingerprint

Oral Contraceptives
Smoke
Tobacco Products
Progesterone
Smoking
Reward
Estradiol
Hormones
Confidence Intervals
Psychology
Gonadal Steroid Hormones
Testing
Proxy
Menstrual Cycle
Research
Placebos
Recurrence

Keywords

  • Cigarette smoking-related symptomatology
  • Progesterone
  • Sex hormones
  • Women's health

PubMed: MeSH publication types

  • Journal Article

Cite this

Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke. / Harrison, Katherine; Petersen, Ashley; Tosun, Nicole; Crist, Katherine; Allen, Alicia M.; Allene, Sharon.

In: Addictive Behaviors, Vol. 102, 106148, 03.2020.

Research output: Contribution to journalArticle

Harrison, Katherine ; Petersen, Ashley ; Tosun, Nicole ; Crist, Katherine ; Allen, Alicia M. ; Allene, Sharon. / Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke. In: Addictive Behaviors. 2020 ; Vol. 102.
@article{576d37a20ae34967bb27f96998684c1c,
title = "Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke",
abstract = "Cigarette smoking-related symptomatology (e.g., craving; SRS) is linked to relapse after a quit attempt. SRS varies by menstrual phase, possibly due to variations in sex hormones (e.g., progesterone), though much of the research to-date has relied on observations from the menstrual cycle acting as a proxy for hormone levels. The goal of this study was to examine the effect of exogenous progesterone on SRS during ad libitum smoking and following overnight abstinence. Oral contraceptive users who smoked completed two 9-day crossover testing periods (7 days of ad libitum smoking and 2 days following overnight abstinence) while taking double-blind active/placebo exogenous progesterone. Participants completed questionnaires to measure SRS. The effect of exogenous progesterone and endogenous hormones (progesterone, estradiol, and progesterone-to-estradiol [P/E2] ratio) on SRS was assessed with paired t-tests and linear mixed effect models. Participants (n = 53) were, on average, 24 years old and smoked 11 cigarettes per day. During ad libitum smoking, a doubling of the P/E2 ratio was associated with 0.09 points lower anticipated relief from negative affect (95{\%} confidence interval [CI]: 0.03–0.15 points lower; p = 0.008) and 0.11 points lower psychological reward (95{\%} CI: 0.03–0.18 points lower; p = 0.006). After correction for multiple testing, these associations were not statistically significant: anticipated relief from negative effect (p = 0.10) and psychological reward (p = 0.09). No other significant associations were observed. Although substantial previous literature indicates that progesterone influences SRS, exogenous progesterone administration did not alter SRS here. Additional research is needed to elucidate alternative mechanisms involved in menstrual phase effects on SRS.",
keywords = "Cigarette smoking-related symptomatology, Progesterone, Sex hormones, Women's health",
author = "Katherine Harrison and Ashley Petersen and Nicole Tosun and Katherine Crist and Allen, {Alicia M.} and Sharon Allene",
year = "2020",
month = "3",
doi = "10.1016/j.addbeh.2019.106148",
language = "English (US)",
volume = "102",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke

AU - Harrison, Katherine

AU - Petersen, Ashley

AU - Tosun, Nicole

AU - Crist, Katherine

AU - Allen, Alicia M.

AU - Allene, Sharon

PY - 2020/3

Y1 - 2020/3

N2 - Cigarette smoking-related symptomatology (e.g., craving; SRS) is linked to relapse after a quit attempt. SRS varies by menstrual phase, possibly due to variations in sex hormones (e.g., progesterone), though much of the research to-date has relied on observations from the menstrual cycle acting as a proxy for hormone levels. The goal of this study was to examine the effect of exogenous progesterone on SRS during ad libitum smoking and following overnight abstinence. Oral contraceptive users who smoked completed two 9-day crossover testing periods (7 days of ad libitum smoking and 2 days following overnight abstinence) while taking double-blind active/placebo exogenous progesterone. Participants completed questionnaires to measure SRS. The effect of exogenous progesterone and endogenous hormones (progesterone, estradiol, and progesterone-to-estradiol [P/E2] ratio) on SRS was assessed with paired t-tests and linear mixed effect models. Participants (n = 53) were, on average, 24 years old and smoked 11 cigarettes per day. During ad libitum smoking, a doubling of the P/E2 ratio was associated with 0.09 points lower anticipated relief from negative affect (95% confidence interval [CI]: 0.03–0.15 points lower; p = 0.008) and 0.11 points lower psychological reward (95% CI: 0.03–0.18 points lower; p = 0.006). After correction for multiple testing, these associations were not statistically significant: anticipated relief from negative effect (p = 0.10) and psychological reward (p = 0.09). No other significant associations were observed. Although substantial previous literature indicates that progesterone influences SRS, exogenous progesterone administration did not alter SRS here. Additional research is needed to elucidate alternative mechanisms involved in menstrual phase effects on SRS.

AB - Cigarette smoking-related symptomatology (e.g., craving; SRS) is linked to relapse after a quit attempt. SRS varies by menstrual phase, possibly due to variations in sex hormones (e.g., progesterone), though much of the research to-date has relied on observations from the menstrual cycle acting as a proxy for hormone levels. The goal of this study was to examine the effect of exogenous progesterone on SRS during ad libitum smoking and following overnight abstinence. Oral contraceptive users who smoked completed two 9-day crossover testing periods (7 days of ad libitum smoking and 2 days following overnight abstinence) while taking double-blind active/placebo exogenous progesterone. Participants completed questionnaires to measure SRS. The effect of exogenous progesterone and endogenous hormones (progesterone, estradiol, and progesterone-to-estradiol [P/E2] ratio) on SRS was assessed with paired t-tests and linear mixed effect models. Participants (n = 53) were, on average, 24 years old and smoked 11 cigarettes per day. During ad libitum smoking, a doubling of the P/E2 ratio was associated with 0.09 points lower anticipated relief from negative affect (95% confidence interval [CI]: 0.03–0.15 points lower; p = 0.008) and 0.11 points lower psychological reward (95% CI: 0.03–0.18 points lower; p = 0.006). After correction for multiple testing, these associations were not statistically significant: anticipated relief from negative effect (p = 0.10) and psychological reward (p = 0.09). No other significant associations were observed. Although substantial previous literature indicates that progesterone influences SRS, exogenous progesterone administration did not alter SRS here. Additional research is needed to elucidate alternative mechanisms involved in menstrual phase effects on SRS.

KW - Cigarette smoking-related symptomatology

KW - Progesterone

KW - Sex hormones

KW - Women's health

UR - http://www.scopus.com/inward/record.url?scp=85074439901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074439901&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2019.106148

DO - 10.1016/j.addbeh.2019.106148

M3 - Article

C2 - 31706140

AN - SCOPUS:85074439901

VL - 102

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

M1 - 106148

ER -